Jeremy Grantham's ABBV Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 6,454 shares of AbbVie Inc. (ABBV) worth $1.47 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in ABBV, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2013, adding 497,890 shares. Largest reduction occurred in Q3 2018, reducing 263,200 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | -338 | Reduce 4.98% | 6,454 | $231.54 |
| Q2 2025 | +940 | Add 16.06% | 6,792 | $185.62 |
| Q1 2025 | -1,381 | Reduce 19.09% | 5,852 | $209.52 |
| Q4 2024 | +1,054 | Add 17.06% | 7,233 | $177.70 |
| Q3 2024 | +6,179 | New Buy | 6,179 | $197.48 |
| Q1 2021 | -31,210 | Sold Out | 0 | $0.00 |
| Q4 2020 | +6,000 | Add 23.80% | 31,210 | $107.15 |
| Q3 2020 | +25,210 | New Buy | 25,210 | $87.58 |
| Q3 2019 | -18,253 | Sold Out | 0 | $0.00 |
| Q2 2019 | +18,253 | New Buy | 18,253 | $72.70 |
| Q4 2018 | -19,253 | Sold Out | 0 | $0.00 |
| Q3 2018 | -263,200 | Reduce 93.18% | 19,253 | $94.58 |
| Q2 2018 | +162,253 | Add 134.99% | 282,453 | $92.65 |
| Q1 2018 | +105,300 | Add 706.71% | 120,200 | $94.65 |
| Q3 2017 | +400 | Add 2.76% | 14,900 | $88.86 |
| Q2 2017 | +9,000 | Add 163.64% | 14,500 | $72.48 |
| Q1 2017 | +5,500 | New Buy | 5,500 | $65.09 |
| Q2 2014 | -66,200 | Sold Out | 0 | $0.00 |
| Q1 2014 | -217,891 | Reduce 76.70% | 66,200 | $51.40 |
| Q4 2013 | -235,099 | Reduce 45.28% | 284,091 | $52.81 |
| Q3 2013 | +497,890 | Add 2337.51% | 519,190 | $44.73 |
| Q2 2013 | +21,300 | Add 0.00% | 21,300 | $41.36 |
Jeremy Grantham's AbbVie Investment FAQs
Jeremy Grantham first purchased AbbVie Inc. (ABBV) in Q2 2013, acquiring 21,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held AbbVie Inc. (ABBV) for 24 quarters since Q2 2013.
Jeremy Grantham's largest addition to AbbVie Inc. (ABBV) was in Q3 2013, adding 519,190 shares worth $23.22 M.
According to the latest 13F filing for Q4 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 6,454 shares of AbbVie Inc. (ABBV), valued at approximately $1.47 M.
As of the Q4 2025 filing, AbbVie Inc. (ABBV) represents approximately 0.00% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in AbbVie Inc. (ABBV) was 519,190 shares, as reported at the end of Q3 2013.